I want to know more about how exercising gives you a better chance of recovering from colon cancer. I've been trying to help ...

Patients in a structured exercise program experienced a 37 per cent lower risk of death and a 28 per cent reduction in ...

Zanzalintinib plus Tecentriq significantly improved overall survival versus Stivarga in previously treated metastatic ...

Colorectal cancer (CRC) is the second most common cause of death from cancer in the United States (US) and the most prevalent ...

Across the globe, colorectal cancer rates have skyrocketed, especially among millennials, with a 2024 study published by The Lancet showing those born in 1990 being two to three times more likely ...

A groundbreaking study reveals that regular exercise significantly improves outcomes for cancer patients. Colon cancer ...

A stomach pain is usually harmless However if the discomfort continues and lingers on for weeks it could indicate serious ...

Exelixis' STELLAR-303 trial shows zanzalintinib plus Tecentriq improved survival in colorectal cancer, with no new safety ...

Participants in the exercise program had a 37 percent lower risk of dying and a 28 percent lower risk of recurrent or new ...

New trial results reveal zanzalintinib and atezolizumab significantly enhance survival in metastatic colorectal cancer, ...

Survival highest when colorectal cancer is diagnosed before other cancers, study finds by American College of Surgeons edited by Sadie Harley, reviewed by Robert Egan Editors' notes ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...